logo-loader

NA Proactive news snapshot: Karora Resources, Hill Street Beverage Company, Medexus Pharmaceuticals, American Manganese UPDATE ...

Last updated: 17:03 02 Mar 2021 EST, First published: 10:35 02 Mar 2021 EST

Newspapers and laptop

Analysts at Canaccord Genuity have maintained their ‘Buy’ rating on Karora Resources Inc (TSE:KRR) with a C$6.75 price target after the miner wrapped up drilling at the Spargos Reward gold project in Australia. The Canaccord analysts noted that drilling at Spargos extended the high-grade gold plunging shoot to over 300m down-plunge, intersecting 6.1 g/t gold over 14m, including 8.6 g/t over 5.7m. “The identification of the high-grade shoot extending to depth also shows the potential to transition this operation from open pit to underground,” the analysts said. “With the pits only planned to 100m, an underground scenario could substantially extend the future mine life at Spargos.” The analysts also noted the company’s exploration budget is 33% bigger for 2021, and said they expect to see the reserves and resources grow again in Karora's September 2021 update.

Hill Street Beverage Company Inc (CVE:BEER) (OTCMKTS:HSEEF) posted fiscal second quarter results Tuesday, revealing rising net revenue and a narrowing net loss in its first quarterly report since acquiring the cannabis assets of Lexaria Biosciences Corp (CSE:LXX) (OTCMKTS:LXRP) on December 9. In the three months ended December 31, Hill Street saw net revenue grow 8% to C$745,748 from C$689,276 in the same period of 2019. The net loss improved 50% to C$481,000 from C$956,000, which the company attributed to increased online sales revenues of 166%, improved gross margin and cost management efforts.

Medexus Pharmaceuticals Inc (CVE:MDX) (OTCQX:MEDXF) shares rose Tuesday after the company posted a record C$31.5 million revenue in its fiscal 3Q results, prompting analysts at Mackie Research Capital Corporation to reiterate its Speculative Buy rating and C$9 price target. “MDP’s key drugs demonstrated solid unit demand growth,” the firm wrote in a note to clients. “Additionally, the company recently renewed and expanded its distribution agreement for [its head lice treatment] NYDA, as well as has been in a full launch of [tumor imaging powder] Gleolan in Canada.” Shares of Medexus climbed more than 6% to C$7.46 Tuesday afternoon.

American Manganese Inc (CVE:AMY) (OTCQB:AMYZF) announced Tuesday that its shares will start trading on the OTCQB Venture Market on Wednesday, March 3. The Surrey, BC-based company’s shares will trade under the symbol ‘AMYZF’ in the US and continue to trade on the TSX Venture Exchange under its existing symbol ‘AMY’ and the Frankfurt Stock Exchange under its existing symbol ‘2AM’. The listing will help American Manganese, a critical metals company focused on recycling of lithium-ion batteries, broaden its investor base in the US and enhance liquidity for current shareholders, CEO Larry Reaugh said in a statement Tuesday.

Altiplano Metals Inc. (CVE:PN) has reported January 2021 production results from the Farellon Copper-Gold (Cu-Au) mine located near La Serena, Chile. During January 2021, the company noted, Farellon produced approximately 3,480 tonnes of mineralized Cu/Au material at an approximate grade of 1.8% copper with shipments for processing totaling 2,770 tonnes. Altiplano said January revenue (after processing costs) generated US$220,000 from the sale of 151,960 pounds of copper compared with US$150,000 and 90,660 pounds of copper in December. At the January month-end, an additional 610 tonnes were stockpiled and available to be shipped.

Biocept Inc (NASDAQ:BIOC) and privately held life sciences company Aegea Biotechnologies Inc have announced a supply agreement for a new PCR-based coronavirus (COVID-19) assay kit designed by Aegea and co-developed by the two companies. Under the agreement, Aegea will supply the COVID-19 assay kit to Biocept for validation in its CLIA-certified, CAP-accredited high-complexity molecular lab and subsequent commercialization of a laboratory-developed test (LDT). The new COVID-19 assay is a PCR-based test using Biocept’s Switch-Blocker technology for viral RNA detection and discrimination of the L and S coronavirus strain types.

Nextleaf Solutions Ltd (CSE:OILS) (OTCQB:OILFF) expects to build its client base and strike more commercial orders in 2021, the cannabis processor told investors, as it reported record unaudited revenue in its first quarter to end-December 2020. The period was the company's first full three months of generating processing revenue and the figure came in at C$1.257 million in the quarter - a 359% increase compared to the same period a year earlier.

CleanSpark Inc (NASDAQ:CLSK) has secured for delivery an additional 2,500 ASIC mining rigs to provide an estimated 218 Petahashs per second (PH/s) of Bitcoin mining capacity. The miners are expected to be delivered and immediately deployed throughout June and July 2021, the company said. Nevada-based CleanSpark said the delivery dates are aligned with the expected completion of energy and infrastructure projects that will provide an additional 30 megawatts (MW) of electricity to the site at a rate of $0.0285/kwh.

Co-Diagnostics Inc (NASDAQ:CODX) has announced the development of a new at-home PCR-based coronavirus (COVID-19) testing, screening and surveillance platform that delivers rapid results via smartphone. The small cube-shaped device is designed to perform COVID-19 testing at businesses, schools, homes, hotels, cruise ships, airports, airplanes and other locations. It relies on the company's Direct Saliva extraction-free process and Logix Smart test reagents that are pre-packaged in saliva receptacle tubes.

BioLargo Inc (OTCQB:BLGO) announced Tuesday that it has paid off $650,000 in debt, the bulk of which was scheduled to mature in August 2021. In a statement, the company said that, aside from the debt carried by its partially owned subsidiary Clyra Medical, only SBA loans and fixed-price convertible debt remain on BioLargo's balance sheet. BioLargo said these actions are directly in line with the company's goals to aggressively reduce or eliminate its convertible debt instruments in favor of equity-based transactions and eliminate costly interest expenses.

HealthLynked Corp (OTCQB:HLYK) said it has received a $2 million equity investment from a family office located in Naples, Florida. HealthLynked shares climbed 20% to $0.78 in early Tuesday trading following the announcement. “We are incredibly pleased to have the support of a Naples based local family office, and they have indicated a strong interest to make an additional investment at the time of our planned up-listing to the Nasdaq exchange,” HealthLynked  CEO Dr Michael Dent said in a statement.

VR Resources Ltd (CVE:VRR) (OTCQB:VRRCF) (FRA:5VR) said Phase 1 of a planned two-stage reverse circulation (RC) drill program is now underway at the Reveille silver-copper property in Nevada. The aim is to complete north of 1,500 metres drilling in five to six holes during the next two weeks. VR CEO Michael Gunning said the goal as "simple", namely, a greenfields discovery which identifies for the first time silver and copper mineralization "proximal to the source and driver to the overall CRD mineral system responsible for the array of high-grade showings and historic workings in the south Reveille range".

Milestone Scientific Inc (NYSEAMERICAN:MLSS), a leading developer of computerized drug delivery instruments that provide virtually painless and precise injections, said Tuesday it has begun selling CompuFlo/CathCheck disposables to the Medical University of South Carolina (MUSC). The MUSC University Medical Center is a nationally recognized and leading health sciences university, recently ranked as the number one hospital in South Carolina, the company noted. MUSC Health owns and operates eight hospitals and provides patient care throughout the state.

Falcon Gold Corp (CVE:FG) (OTCPINK:FGLDF) announced that it has received the preliminary gold analyses for the balance of drill hole CC 20-12 and for all of the holes CC 20-13 and CC 20-14 from the company’s Central Canada gold mine project in northern Ontario, in which another high-grade vein was identified 2.2 meters (m) below the main zone. The company said the new results included an intersection of 10.80 grams per tonne (g/t) gold over a length of 30 centimetres (cm). “We are continuing to expand and test new boundaries while building a data and knowledge base for a better understanding of the Central Canada gold zones in the mine shaft area. In terms of overall strike length, we have drilled the Central Canada mine trend for a surface distance of 275 m plus, while hitting mineralization to new depths,” Falcon Gold CEO Karim Rayani said in a statement.

Global Energy Metals Corporation (CVE:GEMC) (OTCMKTS:GBLEF) announced plans to acquire a 50% interest in three new battery metal projects on Tuesday. The Vancouver-based company said it had entered into a letter of intent with DG Resource Management for a portion of its Monument Peak copper-silver-gold project in Idaho; Chance Lake nickel-copper-cobalt project in Quebec, and Amiral nickel-copper-PGEs in Quebec. GEMC said that the acquisition is part of an ongoing effort to amass battery metals-rich projects in top-tier mining jurisdictions with exploration and development upside.

Energy Fuels Inc (NYSEAMERICAN:UUUU) (TSE:EFR) has said it is teaming up with Neo Performance Materials (TSE:NEO) on a new US and European rare earth production initiative. The program will produce value-added rare earth products from natural monazite sands, which is a byproduct of heavy mineral sands mined in the southeastern US. Energy Fuels, a Colorado-based mineral company, will process the monazite sands into a mixed rare earth carbonate in Utah to use as feedstock for Neo’s rare earths separation facility in Estonia. The firm is also evaluating the potential to develop separation facilities in the US.

One World Lithium Inc (CSE:OWLI) (OTCMKTS:OWRDF) announced Tuesday that it had closed an oversubscribed non-brokered private placement raising just over C$2.25 million to advance its Salar del Diablo lithium brine property in Mexico. The company had originally planned to raise C$1.5 million, but wound up issuing an additional 15,022,210 units for $751,110.50, netting gross proceeds of $2,251,110.50. All told, OWL issued just over 45 million units priced at C$0.05 in the oversubscribed offering. Each unit consisted of one share and one warrant exercisable at $0.10 per share for a three-year period.

Vuzix Corporation (NASDAQ:VUZI) said it has participated in a private seed investment round announced today by Ox Fulfillment Solutions (formerly Oculogx).  The investment round in Ox was led by MaC Venture Capital and Cortado Ventures and included a minority investment from Vuzix. Ox intends to use the funding to invest in partnerships and help expand its operations to assist more large retail firms in supply chain optimization using machine learning.  "Ox has assembled a very impressive team and built an innovative hands-free smart glasses-based augmented reality order management system that enables retailers to pick orders faster and more accurately than any incumbent technology.  Vuzix is excited to be one of the new strategic investors in Ox and we look forward to partnering and supporting their smart glasses hardware business needs as they begin to scale their solution into brick-and-mortar stores in the coming quarters," said Paul Travers, Vuzix president and chief executive officer.

Western Magnesium Corporation (CVE:WMG) (FRA:3WM) (OTCMKTS:MLYF) said it filed its annual consolidated financial statements for the twelve months ended October 31, 2020, the related management discussion and analysis, and the applicable officer certificates on Monday. The annual filings may be accessed under the company’s profile at www.sedar.com.

Psyched Wellness Ltd (CSE:PSYC) (OTCQB:PSYCF) (FRA:5U9), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, announced Tuesday that it has received the results from its Maximum Tolerated Dosage (MTD) study of AME-1 conducted by KGK Science.  "I am pleased to share the positive results from the individual studies that our CRO is conducting in the pre-clinical study on our behalf for AME-1," Jeff Stevens, CEO of Psyched Wellness, said in a statement. "Today's results pushes us one step closer to our goal of applying to the FDA for a New Dietary Ingredient and to Health Canada for a Natural Health Product Number." 

Tartisan Nickel Corp (CSE:TN) (OTCMKTS:TTSRF) (FRA:8TA) is poised to conduct a geophysical survey at its flagship Kenbridge nickel project in northwest Ontario in a bid to assess potential targets for a drill program. The company has hired Crone Geophysics & Exploration Ltd to complete the surface Time Domain Electromagnetic (TDEM) survey over targets identified to the north of the known nickel, copper, cobalt deposit at Kenbridge. 

Medexus Pharmaceuticals Inc (CVE:MDP) (OTCQX:MEDXF) (FRA:P731) announced its fiscal third-quarter results after the bell Monday, revealing record quarterly revenue of C$31.5 million in the three months ended December 31. The company nearly doubled its revenue year-over-year from C$16.2 million in the same period in 2019, and its revenue for the nine months ended December 31 increased 70% to C$82.7 million from 2019.  Adjusted net loss improved by C$4.7 million to C$500,000, compared to $5.2 million in the same period a year earlier.

O3 Mining Inc (CVE:OIII) (OTCMKTS:OIIIF) unveiled plans on Tuesday to expand the drilling program at its Malartic and Alpha properties, two potential production sites, in Val-d'Or, Québec, in a bid to discover and convert new gold resources. The company aims to sink 250,000 metres (m) during this year and next at the two properties, on top of the 86,000m undertaken in 2019 and 2020.

Delta 9 Cannabis Inc (TSE:DN) (OTCQX:VRNDF) (FRA:V5D1) announced it has completed the final services milestone in its agreement with partner F1NE Cannabis Cultivation Ltd (F1), which resulted in F1 receiving its cannabis micro cultivation licenses from Health Canada.  Delta 9 said it has provided services to F1 as part of a Strategic Cooperation Agreement (SCA) related to cannabis production, development of standard operating procedures and sanitation programs, consulting on Health Canada licensing, marketing services, brand development and other services supporting the acquisition of the Health Canada license.

PlantX Life Inc (CSE:VEGA) (FRA:WNT1) (OTCQB:PLTXF) announced Tuesday interim unaudited results for its third quarter, noting a dramatic month-over-month increase in gross revenue. For the quarter ended December 31, the company said it generated revenue of C$1,832,484, an increase of 298% from C$459,982 in the 2Q. The cost of sales was C$1,465,879 and it achieved a gross margin of 20% -- a 5.7% increase month-over-month. 

DGTL Holdings Inc. (CVE:DGTL) (OTCQB:DGTHF) (FRA:A2QB0L) said it has engaged a leading software engineering firm to develop a version 2.0 of wholly-owned subsidiary, Hashoff LLC's social media CMS product suite. Over the past two months, DGTL said its management team has stewarded a detailed RFP (request for proposal) process and interviewed numerous engineering firm candidates. After a thorough technical review, several software enhancements have been identified to meet scalability goals and the project has been expanded to a version 2.0 of the Hashoff software. The most notable software development will be the integration of top video-based social media applications into Hashoff's marketplace creation products.

GlobeX Data Ltd (CSE:SWIS) (OTCQB:SWISF) (FRA:GDT) is eyeing a global mass market launch of its Sekur secure communications solution in April this year, while the first launch, in the US, is on track to be completed before the end of this month. The tech group will launch plans in the US, Canada, Australia, Switzerland, the EU, the UK and New Zealand and currencies offered will be US, Canadian and New Zealand dollars, as well as Swiss Francs, Euros and the British pound. 

Australis Capital Inc (CSE:AUSA) (OTCMKTS:AUSAF) (FRA:AC4) reported its third quarter 2021 results on Monday evening that saw the company end a transformational period with $7.6 million in cash. Revenue for the quarter came in at $90,000, consisting of consulting fees from BAMM and technology revenue from its Cocoon business, both legacy businesses that do not feature heavily in the Las Vegas-based company’s future plans. In a statement accompanying the results, the cannabis company said it was “positioned for rapid growth” following the closing of two major transactions to acquire cultivation facility construction firm ALPS and Green Therapeutics, a Nevada-based cannabis company.

Q BioMed Inc (OTCQB:QBIO) has announced a supply contract with the US Department of Defense and Veterans Affairs (VA), which will make its cancer bone pain drug available to over 9 million VA beneficiaries. The biotech has inked a deal for Strontium89 to be included on the Federal Supply Schedule (FSS) for eligible patients. 

NexTech AR Solutions Corp (OTCQB:NEXCF) (NEO:NTAR) (CSE:NTAR) (FRA:N29) has officially launched its augmented reality (AR) ad network, the company announced Tuesday. NexTech is utilizing its owned and operated virtual event platforms audience, which hosts thousands of specialized events allowing for targeted ads comparable to Facebook, to deliver high- value ads based on people's interests, behaviors, location and demographics. 

PsyBio Therapeutics Corp (CVE:PSYB) announced Tuesday that it has initiated a pilot scale-up of its proprietary biosynthetic formulation of psilocybin in collaboration with Albany Molecular Research Inc. The company said it has completed Phase I of this process, including technology transfer activities, preparation of strain banks, and the adoption of analytical methods while looking forward to communicating additional progress.

Elys Game Technology, Corp. (NASDAQ:ELYS) (NEO:ELYS) has commented on the status of legislation, Bills C-218 and C-13, to legalize single-event sports betting in Canada. The company said it is continuing to monitor legislative developments regarding Bill C-218 that passed on February 17, 2021, with overwhelming bi-partisan support by a margin of 303 votes in favor to 15 votes against. Bill C-218 is now proceeding to hearings before the Justice Committee. Meanwhile, Bill C-13, an Act to Amend the Criminal Code, a similar bill regarding the legalization of single-event sports betting, is anticipated to be taken up by the House of Commons in the near future with additional hearings set for March 9 and 11.

TechX Technologies Inc (CSE:TECX) (OTCMKTS:TECXF) (FRA:C0B:FF) has signed a letter of intent to exchange certain information in pursuit of a potential transaction involving the acquisition of all of the outstanding share capital of Xport Digital Limited, an arms-length party.  In a statement Tuesday, TechX said that Xport Digital is a crypto transfer gateway and digital wallet that offers cryptocurrency purchase services, where users can buy from the listed cryptocurrencies on the platform, including BTC, ETH, and several other altcoins and tokens using a wide selection of payment methods. 

Cardiol Therapeutics Inc (TSE:CRDL) (OTCQX:CRTPF) (FSE:CT9) announced Tuesday that it has submitted an application to uplist its shares to the tech-laden Nasdaq stock exchange in the US. In a statement, CEO David Elsley told investors that the firm sees it an “opportune time” for Cardiol to formally apply for an uplisting. "We believe a Nasdaq listing will provide an ideal platform on which to build a leadership position in the treatment of inflammatory heart disease while elevating the company's profile within the investment community," Elsley said. The biotechnology firm also revealed that it had received proceeds of over $10 million from the exercise of warrants and stock options.

LexaGene Holdings, Inc., (CVE:LXG) (OTCQB:LXXGF) said it has received approximately C$3.6 million (US$2.9 million) in warrant exercises since the start of 2021. In a statement, Dr Jack Regan, LexaGene’s CEO and founder commented: “Achieving our first commercial sales in combination with a very positive outlook for 2021 has resulted in the appreciation of our share price over the last few months. The receipt of exercised warrants has significantly added to our treasury and puts us in a strong financial position for 2021.”

Heritage Cannabis Holdings Corp (CSE:CANN) (OTCQX:HERTF) (FRA:2UE) reported fiscal 2020 gross revenue of $9.3 million, even as COVID-19 weighed on the company’s first full year of sales. Heritage Cannabis noted that its revenue in FY2020 was composed primarily of proceeds from third-party contracts, as branded provincial sales didn’t start until late 2020. 

Numinus Wellness Inc (CVE:NUMI) told investors that it is making “significant progress” in its compassionate access trial of Psilocybin-Research Intervention with Motivational Enhancement (PRIME) for substance use disorders. The trial, which is being run in conjunction with contract research organization Syreon Corporation, will look at the efficacy and safety of psilocybin-assisted motivational enhancement therapy. Numinus said that it has finalized the study protocol after it went through two rounds of peer review by a leading psychedelic research foundation and appointed new experts to the study.

KULR Technology Group Inc (OTCQB:KULR) has announced the appointment of Morio Kurosaki to the company’s board as an independent director. The company said Kurosaki, a seasoned executive and investor in Japan's information technology industry, brings global go-to-market strategy and scalability as the company moves toward its next chapter of product commercialization. “Mr Kurosaki has a unique and extensive ability to provide hands-on experience and support in scaling all phases of growth, such as strategic partnerships and business development in the Asia-Pacific region,” KULR Technology Group CEO Michael Mo said in a statement.

Fidelity Minerals Corp (CVE:FMN) (FRA:S5GM) has unveiled key changes at the top as part of a bid to further advance its project portfolio, including the naming of a new CEO and chairman. Former Rio Tinto PLC geologist and manager, Dean Pekeski has been appointed as the company's chief executive and president effective from March 1, 2021, replacing the current CEO Ian Graham, who will remain as an independent board director. Meanwhile, Fidelity's chairman Bahay Ozcakmak, has resigned to focus on his executive responsibilities at Parkway Minerals. He will be replaced as chairman by John Byrne, the chairman of Lions Bay Capital, a strategic shareholder, which holds 42.9% of the company.

Goldcore Resources Ltd. (CVE:GEM) (FRA:BK2P) said its board of directors have approved a change of the company's name to Green Battery Minerals Inc.  The company said the new name has been chosen to better reflect its strategic focus on working towards the exploration for, and development of green commodities required by the burgeoning Lithium-Ion battery market.  It added that its sustainability focus will reflect in its enhanced attention to ESG (Environmental, Social, and Corporate Governance) matters, which will underpin the company’s aggressive growth plans. 

WeedMD Inc. (CVE:WMD) (OTCQX:WDDMF) (FRA:4WE) said that, further to its press release dated February 11, 2021, announcing a $17.5 million bought deal financing, it has amended the terms of the offering to issue to the underwriters 31,250,000 units at a price per unit of $0.48 for gross proceeds of $15 million. The company has also amended the over-allotment option to allow for purchases by the underwriters of up to an additional 4,687,500 units at the issue price, exercisable in whole or in part, at any time on or prior to the date that is 30 days following the closing of the offering. If this option is exercised in full, an additional approximately $2.25 million will be raised and the aggregate proceeds of the offering will be approximately $17.25 million. All other terms of the offering remain unchanged. The company said it intends to use the net proceeds of the offering for working capital and general corporate purposes.

Aftermath Silver Ltd. (CVE:AAG) (OTCQB:AAGFF) announced that its common shares are now eligible for electronic clearing and settlement through The Depository Trust Company (DTC) in the United States. DTC manages the electronic clearing and settlement of publicly-traded companies in the United States. DTC eligibility simplifies the process of trading and transferring the Company's common shares between brokerages in the United States. Aftermath's common shares will continue to trade under the ticker symbol "AAGFF" on the OTCQB. "Buying Aftermath's shares will now be easier for existing and potential shareholders in the United States," said Michael Williams, Aftermath Silver's chairman. "We believe this will enhance our trading liquidity in the United States and should speed up the execution of transactions in our stock."

PsyBio Therapeutics Corp. (CVE:PSYB), a biotechnology company developing a new class of drugs intended for the treatment of mental health challenges and other disorders which started trading on the TSX Venture Exchange on February 25, 2021, following the reverse takeover of Leo Acquisitions Corp., has announced the release of the unaudited financial results of Leo Acquisition for the six month period ended December 31, 2020. A copy of the unaudited consolidated financial statements prepared in accordance with International Financial Reporting Standards and the corresponding management’s discussion and analysis for the three and six months ended December 31, 2020, can be found under PsyBio’s profile at www.sedar.com.

NetCents Technology Inc. (CVE:NC) has said it does not anticipate being in a position to file its audited annual financial statements, management's discussion and analysis, and related certifications for the fiscal year ended October 31, 2020, on or before March 1, 2021, as required, due to delays caused by the required review of certain new internal control procedures that have been implemented by the issuer. Accordingly, the company has requested the issuance of a management cease trade order under the provisions of National Policy 12-203 (Cease Trade Orders for Continuous Disclosure Defaults) so as to permit the continued trading in the company's common shares by persons other than insiders and employees of the company. The company's staff is working diligently with its auditor, and the company expects to have the audit of the issuer statements completed, and the issuer statements filed, no later than March 26, 2021.

FansUnite Entertainment Inc. (CSE:FANS) (OTCQB:FUNFF) has announced that it will participate in the 4th Annual Gravitas Growth Conference which will be hosted in-person at the Fairmont Pacific Rim Hotel in Downtown Vancouver, and virtually on March 4, 2021.  The FansUnite management team which includes chief executive officer, Scott Burton and President, Darius Eghdami will present at 1.10pm PST at the one-day conference hosted by Gravitas Securities Inc. During the conference, they will also host individual investor meetings and presentations. "We are honoured to be invited to present at the 4th Annual Gravitas Growth Conference," said Burton. "The conference will not only give us the opportunity to share our story with a large audience that consists of institutional investors but also, enable us to promote the fast-growing online betting industry to the investment community." To register for the event, investors can use the following link: https://www.cvent.com/c/express/7a21d04d-9282-4c69-b30c-1ab5caed5d40

Kintara Therapeutics, Inc. (NASDAQ:KTRA), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, has announced that its president and CEO Saiid Zarrabian will present at the H.C. Wainwright Global Life Sciences Conference taking place March 9-10, 2021. The presentation will be available on-demand beginning at 7.00am ET on Tuesday, March 9, 2021, and will be available for 90 days. Zarrabian will also be available for virtual one-on-one meetings on March 9-10, 2021 and meeting requests can be made once registered. Conference registration can be accessed via the following link: https://my.ct.events/register.aspx?meid=fc99b171-2574-4558-bda3-3ba391b6e555&rpid=75ab29bf-f328-45e8-9008-d5e88edeea28

TRACON Pharmaceuticals (NASDAQ:TCON), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics has announced that Charles Theuer, its president and chief executive officer, will present a corporate overview at the H.C. Wainwright Global Life Sciences Conference, being held virtually March 9-10, 2021. The presentation will be available on-demand beginning on Tuesday, March 9, 2021, in the Investors section on the company’s website at www.traconpharma.com.

Arcadia Biosciences, Inc. (NASDAQ:RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, has announced that it will be presenting at the H.C. Wainwright Global Life Sciences Conference, which will be held virtually March 9-10, 2021. Matt Plavan, Arcadia's president and CEO will present an overview of the company's business and will be available for one-on-one web meetings with investors. Institutional investors may request a meeting by registering for the conference at www.hcwevents.com/globalconference. The presentation will be available on-demand starting on March 9.2021, at 7:00an EST at https://journey.ct.events/view/4e96cbea-86d3-4bb8-be67-7dc8f0a588ef. A replay will be available in the Investors section of the company's website.

OTC Markets Group Inc. (OTCQX:OTCM), the operator of financial markets for 11,000 US and global securities, has announced that Ares Strategic Mining Inc (CVE:ARS) (OTCQX: ARSMF), a Vancouver, Canada based mining company, has qualified to trade on the OTCQX Best Market and has today upgraded from the OTCQB Venture Market. The OTCQX Market is designed for established, investor-focused US and international companies. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws. Graduating to the OTCQX Market from the OTCQB Market marks an important milestone for companies, enabling them to demonstrate their qualifications and build visibility among US investors.

ARway.ai announces multiple new SaaS developer contracts in both the United...

ARway.ai (CSE:ARWY, OTCQB:ARWYF) Chief Executive Officer Evan Gappelberg joined Steve Darling from Proactive to announce multiple new SaaS developer sign-ups for its augmented reality experience platform, focusing on AR indoor navigation. These partnerships represent significant milestones in...

1 hour, 59 minutes ago